Nestle to Buy Skin Care Rights From Valeant

Nestle to Buy Skin Care Rights From Valeant Play

May 28 (Bloomberg) -- Nestle said it will expand its skincare unit in North America by buying commercial rights to sell some Valeant Pharmaceuticals products for $1.4 billion in cash. Caroline Hyde has more on Bloomberg Television's "Countdown." (Source: Bloomberg)

  • On Air Now

    PAID PROGRAMMING Watch Now

  • Next

    PAID PROGRAMMING

blog comments powered by Disqus